This was the focus of the 25th Annual Conference on Alzheimer’s Disease and Related Dementias, which was hosted by the MIND ...

The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

Researchers used whole-genome sequencing from diverse populations to identify 156 variants, including 133 novel ones, linked ...

How does Alzheimer's differ from other dementias? The physical changes that happen in a patient's brain are considered to be some of the main features of Alzheimer's disease.

The dollar figures only tell part of the story, however. Those who care for people with Alzheimer’s or other dementias report that both their physical and mental health suffers.

BOSTON — Menopause is a neurologic transition involving metabolic and immune systems of the brain, and timely estrogen therapy could reduce the risk for developing dementias and other ...

The recent passing of beloved UNC sports radio broadcaster Woody Durham has brought attention to a lesser known type of dementia called primary progressive aphasia (PPA). The neurocognitive ...

In 2014, there were 5 million people in the U.S. with Alzheimer's disease and related dementias – about 1.6 percent of the U.S. population. That number is projected to grow to 13.9 million ...